Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Susan Collins
Pharma
Aduhelm still has big sales potential, RBC doctors' survey says
A recent doctors' survey, conducted by RBC Capital Markets, shows a strong market exists for Aduhelm, with potential for $8 billion in sales.
Kevin Dunleavy
Mar 3, 2022 2:00pm
If Trump teams with Dems, pricing bills might actually pass: analyst
Jan 14, 2019 10:46am
Democrats target drug pricing again in new economic plan
Jul 24, 2017 11:17am
Mylan plans a discounted EpiPen generic. Too little, too late?
Aug 29, 2016 9:47am
Mylan's 'cynical' EpiPen access plans trigger new outcry
Aug 26, 2016 8:50am
Hillary drug-price tweet tanks biopharma stocks again
Aug 25, 2016 11:03am
